The cutoff of transient elastography for the evaluation of portal hypertension should be different according to the etiology?
Beom Kyung Kim
Clin Mol Hepatol. 2021;27(1):91-93.   Published online 2020 Dec 3     DOI:
Citations to this article as recorded by Crossref logo
Non-invasive tests-based risk stratification: Baveno VII and beyond
Georg Semmler, Mathias Jachs, Mattias Mandorfer
Clinical and Molecular Hepatology.2023; 29(1): 105.     CrossRef
Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
Susana G Rodrigues
Clinical and Molecular Hepatology.2023; 29(1): 110.     CrossRef
The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus
Jeong-Ju Yoo, Sang Gyune Kim
Clinical and Molecular Hepatology.2023; 29(1): 102.     CrossRef
Limited diagnostic value of liver stiffness for clinically significant portal hypertension in HBV-related cirrhosis
Mengmeng Zhang, Xiaoxia Niu, Di Zhao, Ruping Qi, Xuexin Qi, Jinghui Dong, Yuan Liu, Xu Bai, Qiang Yu, Changchun Liu, Jianming Cai
Abdominal Radiology.2022; 47(11): 3712.     CrossRef